Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn
Research ArticleSpecial Issue IUPHAR Compendium of the Pharmacology and Classification of the Nuclear Receptor Superfamily 2006

International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor α, Farnesoid X Receptor β, Liver X Receptor α, Liver X Receptor β, and Vitamin D Receptor

David D. Moore, Shigeaki Kato, Wen Xie, David J. Mangelsdorf, Daniel R. Schmidt, Rui Xiao and Steven A. Kliewer
Pharmacological Reviews December 2006, 58 (4) 742-759; DOI: https://doi.org/10.1124/pr.58.4.6
David D. Moore
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas (D.D.M., R.X.); The Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan (S.K.); Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, Pennsylvania (W.X.); Howard Hughes Medical Institute, Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S.); and Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S., S.A.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shigeaki Kato
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas (D.D.M., R.X.); The Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan (S.K.); Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, Pennsylvania (W.X.); Howard Hughes Medical Institute, Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S.); and Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S., S.A.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wen Xie
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas (D.D.M., R.X.); The Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan (S.K.); Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, Pennsylvania (W.X.); Howard Hughes Medical Institute, Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S.); and Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S., S.A.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. Mangelsdorf
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas (D.D.M., R.X.); The Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan (S.K.); Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, Pennsylvania (W.X.); Howard Hughes Medical Institute, Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S.); and Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S., S.A.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel R. Schmidt
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas (D.D.M., R.X.); The Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan (S.K.); Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, Pennsylvania (W.X.); Howard Hughes Medical Institute, Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S.); and Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S., S.A.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rui Xiao
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas (D.D.M., R.X.); The Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan (S.K.); Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, Pennsylvania (W.X.); Howard Hughes Medical Institute, Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S.); and Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S., S.A.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven A. Kliewer
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas (D.D.M., R.X.); The Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan (S.K.); Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, Pennsylvania (W.X.); Howard Hughes Medical Institute, Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S.); and Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S., S.A.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 58 no. 4 742-759
DOI 
https://doi.org/10.1124/pr.58.4.6
PubMed 
17132852

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0031-6997
Online ISSN 
1521-0081
History 
  • Published online November 28, 2006.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. David D. Moore,
  2. Shigeaki Kato,
  3. Wen Xie,
  4. David J. Mangelsdorf,
  5. Daniel R. Schmidt,
  6. Rui Xiao, and
  7. Steven A. Kliewer
  1. Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas (D.D.M., R.X.); The Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan (S.K.); Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, Pennsylvania (W.X.); Howard Hughes Medical Institute, Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S.); and Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S., S.A.K.)
  1. Address correspondence to: Dr. David D. Moore, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030. E-mail: moore{at}bcm.tmc.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: January 2018 to March 2023

AbstractFullPdf
Jan 20189377
Feb 201845232
Mar 201894523
Apr 2018013617
May 201814612
Jun 201802717
Jul 201823519
Aug 201812012
Sep 201813310
Oct 201833013
Nov 201813116
Dec 201857178
Jan 20194932
Feb 20197821
Mar 20195953
Apr 20194322
May 20193372
Jun 20195475
Jul 20192621
Aug 20193844
Oct 20192221
Nov 20196253
Dec 201914543
Jan 202014001
Feb 202024300
Mar 202019132
May 20207155
Jun 20201511
Jul 20203841
Aug 20201925
Sep 20203454
Oct 20202994
Nov 202071920
Dec 202094315
Jan 2021173228
Feb 2021303116
Mar 2021164213
Apr 2021183418
May 202145110
Jun 202111246
Jul 202162523
Aug 202123207
Sep 202131715
Oct 2021163320
Nov 20214205
Dec 202171913
Jan 20226236
Feb 202232010
Mar 202252410
Apr 202283417
May 202229278
Jun 202283821
Jul 202262316
Aug 202273919
Sep 202252216
Oct 202273518
Nov 202274312
Dec 202273919
Jan 2023145519
Feb 202342211
Mar 202335711

PreviousNext
Back to top

In this issue

Pharmacological Reviews: 58 (4)
Pharmacological Reviews
Vol. 58, Issue 4
1 Dec 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Pharmacological Reviews article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor α, Farnesoid X Receptor β, Liver X Receptor α, Liver X Receptor β, and Vitamin D Receptor
(Your Name) has forwarded a page to you from Pharmacological Reviews
(Your Name) thought you would be interested in this article in Pharmacological Reviews.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleSpecial Issue IUPHAR Compendium of the Pharmacology and Classification of the Nuclear Receptor Superfamily 2006

International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor α, Farnesoid X Receptor β, Liver X Receptor α, Liver X Receptor β, and Vitamin D Receptor

David D. Moore, Shigeaki Kato, Wen Xie, David J. Mangelsdorf, Daniel R. Schmidt, Rui Xiao and Steven A. Kliewer
Pharmacological Reviews December 1, 2006, 58 (4) 742-759; DOI: https://doi.org/10.1124/pr.58.4.6

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleSpecial Issue IUPHAR Compendium of the Pharmacology and Classification of the Nuclear Receptor Superfamily 2006

International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor α, Farnesoid X Receptor β, Liver X Receptor α, Liver X Receptor β, and Vitamin D Receptor

David D. Moore, Shigeaki Kato, Wen Xie, David J. Mangelsdorf, Daniel R. Schmidt, Rui Xiao and Steven A. Kliewer
Pharmacological Reviews December 1, 2006, 58 (4) 742-759; DOI: https://doi.org/10.1124/pr.58.4.6
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Structures
    • Endogenous Ligands
    • Synthetic Ligands and Selective Modulators
    • Genetics
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • International Union of Pharmacology. LIX. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Thyroid Hormone Receptors
  • International Union of Pharmacology. LX. Retinoic Acid Receptors
  • International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors
Show more Special Issue IUPHAR Compendium of the Pharmacology and Classification of the Nuclear Receptor Superfamily 2006

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics